Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Preveceutical Med Inc New (PRVCF)

Preveceutical Med Inc New (PRVCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents Newsfile - Mon Feb 9, 2:02AM CST

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it has...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Expands Financing and Approves Key Resolutions at Annual Meeting Tipranks - Sat Oct 11, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. PreveCeutical...

PRVCF : 0.0168 (+2.44%)
PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics Newsfile - Fri Sep 19, 2025

Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer Newsfile - Wed Aug 20, 2025

Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research Newsfile - Tue Aug 19, 2025

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting Newsfile - Wed Jul 9, 2025

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its News...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer Newsfile - Mon Jun 30, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Announces Date for Annual General and Special Meeting Newsfile - Wed Jun 25, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor Newsfile - Mon Jun 2, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Welcomes Stephen Glover as Corporate Advisor Newsfile - Mon May 26, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)

Barchart Exclusives

This Is the Top-Rated Dividend Stock to Buy in February 2026 Barchart - Tue Feb 10, 6:30PM CST
CMCL’s low payout ratio, hedged $3,500‑floor gold pricing, and 56% implied upside from its lone “Strong Buy” target make it an attractive small‑cap dividend grower for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot